Bristol-Myers Squibb Company (0R1F.IL)
Develops medicines to treat cancer, blood disorders, heart disease, and immune system conditions.
$64.10-0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+46.9%
The outlook
Bristol-Myers Squibb is trading near the upper end of its 52-week range and well above both its 50- and 200-day moving averages, signaling strength in its recent trend. The stock carries a trailing P/E of 17.3 and analyst coverage leans bullish overall. Today's trading was flat.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range96% of the way from its 52-week low to high
Market cap
$137.81B
52-wk high
$65.00
52-wk low
$42.54
50-day avg
$57.60
200-day avg
$55.73
Trailing P/E
17.3